A new drug could dramatically ease the pain and misery of the 60,000 people in the UK who suffer from rheumatoid arthritis. Specialists believe that the drug, Remicade, is a major breakthrough in ...

Increasing aging populations and growing hospital infrastructures will drive demand for rheumatoid arthritis drugs.Wilmington ...

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...

Filgotinib, the rheumatoid arthritis (RA) oral drug that never made it to the U.S. market but is sold across Europe, Great ...

A blockbuster weight-loss drug sharply reduces pain from obesity-related arthritis in the knees and improves people’s ability to engage in activities such as walking. That’s according to a ...

By Hugo Francisco de Souza New research highlights the potential for weight-loss medication to ease arthritis symptoms, ...

Tablets sold as dietary supplements should not have been, according to the U.S. Food and Drug Administration (FDA), after three drugs were ... for joint pain and arthritis, but contained drugs ...

The brain has GLP -1 receptors in abundance and, though very little drug seems to be able to cross the blood-brain barrier ...

In a recent study published in The New England ... in overweight arthritis patients. A once-weekly 2.4 mg subcutaneous injection of the novel antidiabetic wonder drug was observed to reduce ...

Two "key" genes have been identified by scientists linking the painful condition and the bone disease osteoporosis.

The decline was offset by sales of its newer arthritis drugs Skyrizi, which soared by more than 50% to $3.21 billion, and Rinvoq, which logged a 45% gain to $1.61 billion. The company lifted ...

With the discovery of autoantibodies and other risk factors for rheumatoid arthritis ... with new joint symptoms who are at a risk for RA, was presented at the EULAR 2024 Annual Meeting and will be ...